Cited by 165Retinal Diseases and TreatmentsAntioxidant Activity and Oxidative StressRetinal Imaging and Analysis

Vitamin E supplementation and macular degeneration: randomised controlled trial

Open access
Taylor, Hugh R, Tikellis, Gabriella, Robman, Luba D, McCarty, Catherine A, McNeil, John J·2002·BMJ

Abstract

OBJECTIVE: To determine whether vitamin E supplementation influences the incidence or rate of progression of age related maculopathy (AMD). DESIGN: Prospective randomised placebo controlled clinical trial. SETTING: An urban study centre in a residential area supervised by university research staff. PARTICIPANTS: 1193 healthy volunteers aged between 55 and 80 years; 73% completed the trial on full protocol. INTERVENTIONS: Vitamin E 500 IU or placebo daily for four years. PRIMARY OUTCOME: development of early age related macular degeneration in retinal photographs. Other measures included alternative definitions of age related macular degeneration, progression, changes in component features, visual acuity, and visual function RESULTS: The incidence of early age related macular degeneration (early AMD 3) was 8.6% in those receiving vitamin E versus 8.1% in those on placebo (relative risk 1.05, 95% confidence interval 0.69 to 1.61). For late disease the incidence was 0.8% versus 0.6% (1.36, 0.67 to 2.77). Further analysis showed no consistent differences in secondary outcomes. CONCLUSION: Daily supplement with vitamin E supplement does not prevent the development or progression of early or later stages of age related macular degeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.325.7354.11

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A trial of vitamin E in an Australian population with lower risk of developing advanced age-related macular degeneration failed to find a beneficial effect.

    “By contrast, a trial of vitamin E in an Australian population with lower risk of developing advanced age-related macular degeneration failed to find a beneficial effect.97”

    From Age-related macular degeneration (2008) · cites this paper as [97]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A., & McNeil, J. J.
Affiliations
The University of Melbourne (AU)
Corresponding author
Taylor, Hugh R
Venue
BMJ
Publisher
BMJ
Published
2002-07-06
Volume
325
Issue
7354
Pages
11
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2139029875
Cited by
165
References
35
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 7 · 2016: 1 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 17
FWCI
12.76
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
vitamin E supplementation, age-related macular degeneration, disease progression, early AMD, late AMD, fundus images, visual acuity, visual function, older adults
MeSH terms
Aged, Aged, 80 and over, Antioxidants, Follow-Up Studies, Humans, Macular Degeneration, Middle Aged, Prospective Studies, Victoria, Vitamin E, Incidence, Prevalence, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review